Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Maura

Showing results (41-50 of 146) with videos related to

Pageof 15
Sort By:
Leukemia|February 6, 2020
Minimal spatial heterogeneity in chronic lymphocytic leukemia at diagnosisFerran Nadeu, Romina Royo, Francesco Maura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2014
Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantationJacopo Mariotti, Francesco Maura, Francesco Spina, et al.
Bioinformatics (Oxford, England)|July 8, 2025
AncestryGeni: a novel genetic ancestry classification pipeline for small and noisy sequence dataEran Elhaik, Sara Behnamian, Michael Howe, et al.
Blood Cancer Discovery|September 4, 2025
Timing genomic antigen loss in multiple myeloma treated with T-cell redirecting immunotherapiesMarios Papadimitriou, Sungwoo Ahn, Benjamin T Diamond, et al.
Nature Communications|July 27, 2019
Author Correction: A practical guide for mutational signature analysis in hematological malignanciesFrancesco Maura, Andrea Degasperi, Ferran Nadeu, et al.
Nature Communications|July 7, 2019
A practical guide for mutational signature analysis in hematological malignanciesFrancesco Maura, Andrea Degasperi, Ferran Nadeu, et al.
Cancer|May 26, 2017
Next-generation sequencing of a family with a high penetrance of monoclonal gammopathies for the identification of candidate risk allelesNiccolo Bolli, Matteo Barcella, Erika Salvi, et al.
Blood Cancer Journal|July 19, 2024
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
British Journal of Haematology|December 14, 2011
An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patientsAgostino Cortelezzi, Giuseppe Gritti, Luca Laurenti, et al.
Blood Cancer Journal|February 2, 2025
Bruton's tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven by BCL10 gain-of-function mutants to venetoclaxCaroline A Coughlin, Dhanvantri Chahar, Marianna Lekakis, et al.
Pageof 15

Showing results (41-50 of 146) with videos related to

Sort By:
Pageof 15
Leukemia|February 6, 2020
Minimal spatial heterogeneity in chronic lymphocytic leukemia at diagnosisFerran Nadeu, Romina Royo, Francesco Maura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2014
Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantationJacopo Mariotti, Francesco Maura, Francesco Spina, et al.
Bioinformatics (Oxford, England)|July 8, 2025
AncestryGeni: a novel genetic ancestry classification pipeline for small and noisy sequence dataEran Elhaik, Sara Behnamian, Michael Howe, et al.
Blood Cancer Discovery|September 4, 2025
Timing genomic antigen loss in multiple myeloma treated with T-cell redirecting immunotherapiesMarios Papadimitriou, Sungwoo Ahn, Benjamin T Diamond, et al.
Nature Communications|July 27, 2019
Author Correction: A practical guide for mutational signature analysis in hematological malignanciesFrancesco Maura, Andrea Degasperi, Ferran Nadeu, et al.
Nature Communications|July 7, 2019
A practical guide for mutational signature analysis in hematological malignanciesFrancesco Maura, Andrea Degasperi, Ferran Nadeu, et al.
Cancer|May 26, 2017
Next-generation sequencing of a family with a high penetrance of monoclonal gammopathies for the identification of candidate risk allelesNiccolo Bolli, Matteo Barcella, Erika Salvi, et al.
Blood Cancer Journal|July 19, 2024
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
British Journal of Haematology|December 14, 2011
An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patientsAgostino Cortelezzi, Giuseppe Gritti, Luca Laurenti, et al.
Blood Cancer Journal|February 2, 2025
Bruton's tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven by BCL10 gain-of-function mutants to venetoclaxCaroline A Coughlin, Dhanvantri Chahar, Marianna Lekakis, et al.
Pageof 15